Jonathan Chung to Carcinoma, Transitional Cell
This is a "connection" page, showing publications Jonathan Chung has written about Carcinoma, Transitional Cell.
Connection Strength
0.839
-
Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma. Eur Urol Focus. 2021 Nov; 7(6):1339-1346.
Score: 0.167
-
Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions. BJU Int. 2020 05; 125(5):739-746.
Score: 0.161
-
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study. Clin Genitourin Cancer. 2020 10; 18(5):e543-e556.
Score: 0.161
-
Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder. Eur Urol. 2020 04; 77(4):548-556.
Score: 0.160
-
Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study. J Clin Oncol. 2018 12 01; 36(34):3353-3360.
Score: 0.147
-
Targetable gene fusions and aberrations in genitourinary oncology. Nat Rev Urol. 2020 11; 17(11):613-625.
Score: 0.042